| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6092214 | Gastroenterology | 2015 | 48 Pages |
Abstract
TNFR2 protects mice from colitis by inhibiting the expansion of colonic CD8+ T cells. TNFR2 regulates expression of genes that regulate CD8+ T cells and have been associated with susceptibility to IBD. Disruption in TNFR2 signaling might therefore be associated with pathogenesis. Strategies to increase levels or activity of TNFR2 and thereby reduce the activity of CD8+ T cells might be developed to treat IBD patients with CD8+ T cell dysfunction.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Shivesh Punit, Philip E. Dubé, Cambrian Y. Liu, Nandini Girish, M. Kay Washington, D. Brent Polk,